PolyPeptide Group

Drug Solutions Podcast: Forecasting Pharma’s Future

The company says it is the pharmaceutical market’s first wet granulator with an integrated, truly continuous dryer.

January 31st 2025

The 10th Anniversary of the International Day of Women and Girls in Science

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Black female scientist looking through microscope while working in laboratory. | Image Credit: ©Drazen - stock.adobe.com

Susan Haigney

Drug Solutions Podcast: Realizing AI’s Potential

Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.

December 20th 2024

FDA Approves AbbVie Treatment for Complicated Intra-Abdominal Infections

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Expanding Pharma’s Horizons Through AI and Acquisitions

These infections can be caused by certain Gram-negative microorganisms, making the infections challenging to control due to high antimicrobial resistance.

futuristicPill. Image credit: ©Jackie Niam - stock.adobe.com

L.B. Bohle Wet Granulator to Make US Debut at INTERPHEX

Application of AI/ML technology and a burst of M&A activity look to be shaping the future of the pharma industry.

Related Content

Drug Solutions Podcast: Forecasting Pharma’s Future

The company says it is the pharmaceutical market’s first wet granulator with an integrated, truly continuous dryer.

January 31st 2025

The 10th Anniversary of the International Day of Women and Girls in Science

Susan Haigney

Drug Solutions Podcast: Realizing AI’s Potential

Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.

December 20th 2024

FDA Approves AbbVie Treatment for Complicated Intra-Abdominal Infections

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Expanding Pharma’s Horizons Through AI and Acquisitions

These infections can be caused by certain Gram-negative microorganisms, making the infections challenging to control due to high antimicrobial resistance.